XBI UCITS Equivalent: BTEC
XBI (SPDR S&P Biotech ETF, SPDR) is a US-listed ETF you can't buy from Europe. Its closest UCITS equivalent is BTEC — iShares Nasdaq US Biotechnology UCITS ETF — a 80% match by index, holdings and cost.
XBI vs BTEC: side-by-side
| XBI (US) | BTEC (UCITS) | |
|---|---|---|
| Fund | SPDR S&P Biotech ETF | iShares Nasdaq US Biotechnology UCITS ETF |
| Strategy | US biotech (S&P Biotech, equal weight) | US biotechnology |
| Domicile | United States | Ireland |
| Ongoing charge (TER) | — | 0.35% |
| Income | Distributing (quarterly) | Accumulating (reinvests income) |
| Trailing yield | 0% | — (accumulating) |
| Trading currency | USD | USD |
| Fund size | — | 720M |
| Buyable by EU/UK retail investors | Usually blocked (no PRIIPs KID) | Yes |
| US estate-tax exposure (non-US investors) | Yes, above $60k | No |
| US dividend withholding | Withheld on each payout (15% with a W-8BEN, else 30%) | 15% inside the fund (Ireland–US treaty), nothing extra to you |
UCITS data from UCITSIncome, updated November 2026. XBI figures are indicative.
About XBI
Why you can't buy XBI in Europe
US-domiciled ETFs like XBIdon't publish the EU “KID” disclosure document required by the PRIIPs regulation, so European and other non-US brokers block the order. It isn't illegal — you simply buy the UCITS equivalent (BTEC) instead. UCITS funds are also more tax-efficient for non-US investors: lower US dividend withholding and no US estate-tax exposure. Read the full explanation →
Track BTEC and other UCITS income ETFs
Get distribution dates, yield changes and new US→UCITS matches. Free, occasional, no spam.
Similar US ETF equivalents
Matches are based on the underlying index, holdings overlap and cost, sourced from UCITSIncome data. Information only — not financial advice. Always do your own research before investing.